SCHEMBL8360285

SCHEMBL8360285

CC(C)S(=O)(=O)c1cc(C(F)(F)F)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.59
WEE1 P30291 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
GSK3B P49841 3/20 0.34
MAPT P10636 2/20 0.34
CNR1 P21554 2/20 0.34
CNR2 P34972 2/20 0.34
LMNA P02545 2/20 0.34
HTT P42858 1/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
PIK3CD O00329 1/20 0.33
PIK3R2 O00459 1/20 0.33
PIK3CG P48736 1/20 0.33
CYP1A2 P05177 1/20 0.33
KDM4E B2RXH2 1/20 0.32
MAPK1 P28482 1/20 0.32
GAA P10253 1/20 0.32
CDK4 P11802 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285146 0.88 PDE11A (0.56) PDE11AWEE1MEN1KMT2AGSK3B
SCHEMBL8287231 0.86 PDE11A (0.64) PDE11AWEE1MEN1KMT2AGSK3B
SCHEMBL5871948 0.83 PDE11A (0.56) PDE11AWEE1MEN1KMT2AGSK3B
SCHEMBL5872148 0.82 PDE11A (0.60) PDE11AWEE1MEN1KMT2AGSK3B
SCHEMBL8286352 0.82 PDE11A (0.60) PDE11AWEE1MEN1KMT2AGSK3B
SCHEMBL8285157 0.82 PDE11A (0.60) PDE11AWEE1MEN1KMT2AGSK3B
SCHEMBL6879695 0.81 PDE11A (0.66) PDE11AWEE1MEN1KMT2AGSK3B
SCHEMBL5872038 0.81 PDE11A (0.66) PDE11AWEE1MEN1KMT2AGSK3B
SCHEMBL6879687 0.81 PDE11A (0.66) PDE11AWEE1MEN1KMT2AGSK3B
SCHEMBL5871860 0.80 PDE11A (0.65) PDE11AWEE1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed